Press Release Archives
Argos Therapeutics Inc
Argos Therapeutics, Inc. is a biopharmaceutical company, which engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. Its product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Ralph Steinman on May 8, 1997 and is headquartered in Durham, NC.

Argos Therapeutics Inc Press Releases

Press Archives

Argos Therapeutics Inc

Press Archives

The Klein Law Firm Announces a Class Action Has Been Filed on Behalf of Argos Therapeutics, Inc. Shareholders and a Lead Plaintiff Deadline of May 15, 2017

Apr 13th 2017

April 13, 2017 NEW YORK, April 13, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Argos T

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Argos Therapeutics, Inc. (ARGS) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Apr 6th 2017

April 6, 2017 STEVENSON, Md., April 06, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class ac

IMPORTANT ARGOS THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Argos Therapeutics, Inc. in the Middle District of North Carolina

Mar 22nd 2017

Lead Plaintiff Deadline is May 15, 2017

ARGS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Argos Therapeutics, Inc. and a Lead Plaintiff Deadline of May 15, 2017

Mar 20th 2017

March 20, 2017 NEW YORK, March 20, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States D

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Argos Therapeutics, Inc. (ARGS) To Contact Brower Piven Before The Lead Plaintiff Deadline

Mar 17th 2017

March 18, 2017 STEVENSON, Md., March 17, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class a

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Argos Therapeutics, Inc. To Contact The Firm Before Lead Plaintiff Deadline

Mar 16th 2017

March 16, 2017 NEW YORK, March 16, 2017 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Argos Therapeutics, Inc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Argos Therapeutics, Inc.

Mar 15th 2017

Sets Lead Plaintiff Deadline of May 15, 2017 -- ARGS